A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
January 16, 2020
Premier Shares Successful Efforts in the Fight Against Antimicrobial Resistance at Duke Margolis Health Policy Center Event
Soumi Saha, Premier’s Senior Director of Advocacy, is providing comments on how Premier is implementing and measuring improvement efforts in the fight against AMR.
January 08, 2020
Getting the Right Dose
Becker's Hospital Review | Premier’s Daisy Jackson sat down with Jon Faldasz, head of clinical applications for InsightRX, to discuss all things precision dosing.
December 16, 2019
Premier Recommendations to Congress on "Cures 2.0”
Premier offered evidence-based policy recommendations to help Congress develop the next generation of the 21st Century Cures Act.
December 16, 2019
Saving Seconds by Solving the Emergency Syringe Shortage
The reality in emergency rooms across the country is that life-saving drugs vital to patient care just aren’t available.
December 03, 2019
Staying on Top of Accreditation & Regulatory Surveys
It’s essential for providers to be ready at any time for surveyors, especially now that the new USP 800 hazardous drugs regulations are in effect.
November 20, 2019
Premier’s Alkire on Drug Shortages
Bloomberg | Michael Alkire, President of Premier Inc., talks about drug shortages with Lisa Abramowicz and Paul Sweeney. Full Podcast
November 13, 2019
InsightRX and Premier Inc. Partner to Enable Hospitals, Health Systems and Providers to Individualize Treatment for Infectious Disease Patients
InsightRx | Integrated solution aims to decrease serious side effects caused by vancomycin and other antibiotics used to treat infectious diseases
November 05, 2019
Premier Joins 47 Organizations in Supporting the Mitigating Emergency Drug Shortages (MEDS) Act
Premier and 47 national trade associations, health systems and hospitals, pharmacy associations, and small businesses voiced support for the MEDS Act.
October 30, 2019
Premier Statement for the Record for the House Energy and Commerce Subcommittee on Health Hearing on Safeguarding the Pharmaceutical Supply Chain
Premier underscored how drug shortages threaten the security of the pharmaceutical supply chain.
October 29, 2019
Statement on the Introduction of the Mitigating Emergency Drug Shortages Act
Premier strongly supports the MEDS Act (S. 2723), introduced today by Senators Susan Collins (R-ME) and Tina Smith (D-MN).
October 29, 2019
What We’re Watching: October 29, 2019
We hear that major legislation may be introduced this week to address drug shortages.
October 29, 2019
Statement on the FDA Drug Shortage Task Force Report
Premier Statement on the FDA Drug Shortage Task Force report.
October 15, 2019
What We’re Watching: October 15, 2019
Thanks to ProvideGx, the multi-year, national shortage of cysteine hydrochloride injection has been successfully resolved.
October 14, 2019
Premier Cautions DEA on Proposal to Reduce CII Quotas in 2020
Premier submitted comments cautioning the DEA to carefully consider how a reduction in manufacturing quotas for certain opioids could rekindle recent drug shortages.
October 08, 2019
Premier’s ProvideGx™ Program Partners with Amphastar to Provide Seven Shortage Drugs, Most in Emergency, Pre-Filled Syringes
Through its ProvideGx™ program, Premier has partnered with Amphastar Pharmaceuticals, Inc. to supply to healthcare providers phytonadione injection and emergency, pre-filled syringes.
October 08, 2019
Partnership Between Premier’s ProvideGx™ Program and Exela Pharma Sciences, LLC, Successfully Resolves National Shortage of Cysteine Hydrochloride
Premier's ProvideGx™ program and its partnership with Exela Pharma Sciences has successfully resolved the multi-year, national shortage of cysteine hydrochloride injection.
September 20, 2019
InsightRX Raises $10 Million To Personalize Drug Doses
Forbes | InsightRx, a precision medicine company announced the closing of funding with participation from several organizations including Premier.
September 18, 2019
Premier Statement on FDA Action to Address the Use of Citizen Petitions to Delay Market Competition of Generics and Biosimilars
Members of Premier applaud the FDA for finalizing guidance on the use of citizen petitions to delay the market entry of generic medications and biosimilars.
September 16, 2019
Premier Comments on CMS Proposed Requirements for Long-Term Care Facilities
Premier submitted comments to CMS on its proposed rule aiming to reduce burden and redundant requirements in long-term care facilities (LTCFs). In its comments...
September 11, 2019
Premier Inc. Projects 4.2 Percent Price Inflation for Pharmaceuticals
Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies.
September 10, 2019
Premier Comments on Home Infusion Payment and Quality Reporting Policies in CY 2020 Home Health Proposed Rule
Premier continues to urge CMS to amend its misguided policy for Medicare coverage of home infusion therapy services.
